Altered TNSALP expression and phosphate regulation contribute to reduced mineralization in mice lacking androgen receptor

Molecular and Cellular Biology

Volumn 28, Issue 24, 2008, Pages 7354-7367

  Kang, Hong Yo ^a   Shyr, Chih Rong ^a,b   Huang, Chiung Kuei ^a   Tsai, Meng Yin ^a   Orimo, Hideo ^c   Lin, Pei Chun ^a   Chang, Chawnshang ^d   Huang, Ko En ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANDROGEN RECEPTOR; GLYCOPROTEIN; PHOSPHATE; SMALL INTEGRIN BINDING LIGAND N LINKED GLYCOPROTEIN; TISSUE NONSPECIFIC ALKALINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CALCIFICATION; CALVARIA; CELL COUNT; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

3T3 CELLS; ALKALINE PHOSPHATASE; ANDROGENS; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MALE; MICE; MICE, KNOCKOUT; OSTEOBLASTS; PHOSPHATES; RECEPTORS, ANDROGEN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SKULL;

MUS;

EID: 57349156592     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00582-08     Document Type: Article

References (60)

1. Abu, E. O., A. Horner, V. Kusec, J. T. Triffitt, and J. E. Compston. 1997. The localization of androgen receptors in human bone. J. Clin. Endocrinol. Metab. 82:3493-3497.
2. Balkan, W., K. L. Burnstein, P. C. Schiller, C. Perez-Stable, G. D'Ippolito, G. A. Howard, and B. A. Roos. 2005. Androgen-induced mineralization by MC3T3-E1 osteoblastic cells reveals a critical window of hormone responsiveness. Biochem. Biophys. Res. Commun. 328:783-789.
3. Beck, G. R., Jr., and N. Knecht. 2003. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J. Biol. Chem. 278:41921-41929.
4. Beck, G. R., Jr., B. Zerler, and E. Moran. 2000. Phosphate is a specific signal for induction of osteopontin gene expression. Proc. Natl. Acad. Sci. USA 97:8352-8357.
5. Castelo-Branco, C., J. J. Vicente, F. Figueras, A. Sanjuan, M. J. Martinez de Osaba, E. Casals, F. Pons, J. Balasch, and J. A. Vanrell. 2000. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 34:161-168.
6. Choi, J. Y., B. H. Lee, K. B. Song, R. W. Park, I. S. Kim, K. Y. Sohn, J. S. Jo, and H. M. Ryoo. 1996. Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells. J. Cell Biochem. 61:609-618.
7. Czerwiec, F. S., J. J. Liaw, S. B. Liu, C. Perez-Stable, R. Grumbles, G. A. Howard, B. A. Roos, and K. L. Burnstein. 1997. Absence of androgen-mediated transcriptional effects in osteoblastic cells despite presence of androgen receptors. Bone 21:49-56.
8. Denhardt, D. T., and M. Noda. 1998. Osteopontin expression and function: role in bone remodeling. J. Cell Biochem. Suppl. 31:92-102.
9. Eaton, R. H., and D. W. Moss. 1968. Kinetic studies on the orthophosphatase and iorganic pyrophosphatase activities of human alkaline phosphatase. Enzymologia 35:168-178.
10. Fedde, K. N., L. Blair, J. Silverstein, S. P. Coburn, L. M. Ryan, R. S. Weinstein, K. Waymire, S. Narisawa, J. L. Millan, G. R. MacGregor, and M. P. Whyte. 1999. Alkaline phosphatase knockout mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J. Bone Miner. Res. 14:2015-2026.
11. Fisher, L. W., D. A. Torchia, B. Fohr, M. F. Young, and N. S. Fedarko. 2001. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem. Biophys. Res. Commun. 280:460-465.
12. Forbes, A. P. 1991. Fuller Albright. His concept of postmenopausal osteoporosis and what came of it. Clin. Orthop. Relat. Res.:128-141.
13. Francis, R. M., M. Peacock, J. E. Aaron, P. L. Selby, G. A. Taylor, J. Thompson, D. H. Marshall, and A. Horsman. 1986. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 7:261-268.
14. Fujita, T., N. Izumo, R. Fukuyama, T. Meguro, H. Nakamuta, T. Kohno, and M. Koida. 2001. Phosphate provides an extracellular signal that drives nuclear export of Runx2/Cbfa1 in bone cells. Biochem. Biophys. Res. Commun. 280:348-352.
15. Goulding, A., and E. Gold. 1993. Flutamide-mediated androgen blockade evokes osteopenia in the female rat. J. Bone Miner. Res. 8:763-769.
16. Gruber, R., K. Czerwenka, F. Wolf, G. M. Ho, M. Willheim, and M. Peterlik. 1999. Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor alpha- and beta-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/osteoblastic cells. Bone 24:465-473.
17. Heinlein, C. A., and C. Chang. 2002. Androgen receptor (AR) coregulators: an overview. Endocrinol. Rev. 23:175-200.
18. Henthorn, P. S., and M. P. Whyte. 1992. Missense mutations of the tissuenon-specific alkaline phosphatase gene in hypophosphatasia. Clin. Chem. 38:2501-2505.
19. Hough, T. A., M. Polewski, K. Johnson, M. Cheeseman, P. M. Nolan, L. Vizor, S. Rastan, A. Boyde, K. Pritzker, A. J. Hunter, E. M. Fisher, R. Terkeltaub, and S. D. Brown. 2007. Novel mouse model of autosomal semidominant adult hypophosphatasia has a splice site mutation in the tissue nonspecific alkaline phosphatase gene Akp2. J. Bone Miner. Res. 22:1397-1407.
20. Huber, D. M., A. C. Bendixen, P. Pathrose, S. Srivastava, K. M. Dienger, N. K. Shevde, and J. W. Pike. 2001. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor. Endocrinology 142:3800-3808.
21. Ikegami, A., S. Inoue, T. Hosoi, Y. Mizuno, T. Nakamura, Y. Ouchi, and H. Orimo. 1993. Immunohistochemical detection and northern blot analysis of estrogen receptor in osteoblastic cells. J. Bone Miner. Res. 8:1103-1109.
22. Johnson, K., J. Goding, D. Van Etten, A. Sali, S. I. Hu, D. Farley, H. Krug, L. Hessle, J. L. Millan, and R. Terkeltaub. 2003. Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J. Bone Miner. Res. 18:994-1004.
23. Kanatani, M., T. Sugimoto, J. Kano, and K. Chihara. 2002. IGF-I mediates the stimulatory effect of high phosphate concentration on osteoblastic cell proliferation. J. Cell Physiol. 190:306-312.
24. Kang, H. Y., C. L. Cho, K. L. Huang, J. C. Wang, Y. C. Hu, H. K. Lin, C. Chang, and K. E. Huang. 2004. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. J. Bone Miner. Res. 19:1181-1190.
25. Kang, H. Y., K. E. Huang, S. Y. Chang, W. L. Ma, W. J. Lin, and C. Chang. 2002. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J. Biol. Chem. 277:43749-43756.
26. Kang, H. Y., H. K. Lin, Y. C. Hu, S. Yeh, K. E. Huang, and C. Chang. 2001. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc. Natl. Acad. Sci. USA 98:3018-3023.
27. Kang, H. Y., M. Y. Tsai, C. Chang, and K. E. Huang. 2003. Mechanisms and clinical relevance of androgens and androgen receptor actions. Chang Gung Med. J. 26:388-402.
28. Kang, H. Y., S. Yeh, N. Fujimoto, and C. Chang. 1999. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J. Biol. Chem. 274:8570-8576.
29. Kang, Z., O. A. Janne, and J. J. Palvimo. 2004. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol. 18:2633-2648.
30. Kasperk, C., A. Helmboldt, I. Borcsok, S. Heuthe, O. Cloos, F. Niethard, and R. Ziegler. 1997. Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations. Calcif. Tissue Int. 61:464-473.
31. Kawano, H., T. Sato, T. Yamada, T. Matsumoto, K. Sekine, T. Watanabe, T. Nakamura, T. Fukuda, K. Yoshimura, T. Yoshizawa, K. Aihara, Y. Yamamoto, Y. Nakamichi, D. Metzger, P. Chambon, K. Nakamura, H. Kawaguchi, and S. Kato. 2003. Suppressive function of androgen receptor in bone resorption. Proc. Natl. Acad. Sci. USA 100:9416-9421.
32. Manolagas, S. C., S. Kousteni, and R. L. Jilka. 2002. Sex steroids and bone. Recent Prog. Horm. Res. 57:385-409.
33. Mizuno, Y., T. Hosoi, S. Inoue, A. Ikegami, M. Kaneki, Y. Akedo, T. Nakamura, Y. Ouchi, C. Chang, and H. Orimo. 1994. Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells. Calcif. Tissue Int. 54:325-326.
34. Mundy, G., R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, and G. Gutierrez. 1999. Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946-1949.
35. Murshed, M., D. Harmey, J. L. Millan, M. D. McKee, and G. Karsenty. 2005. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 19:1093-1104.
36. Nakano, Y., I. Morimoto, O. Ishida, T. Fujihira, A. Mizokami, A. Tanimoto, N. Yanagihara, F. Izumi, and S. Eto. 1994. The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells. Bone Miner. 26:245-259.
37. Nelson, P. S., N. Clegg, H. Arnold, C. Ferguson, M. Bonham, J. White, L. Hood, and B. Lin. 2002. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl. Acad. Sci. USA 99:11890- 11895.
38. Notini, A. J., J. F. McManus, A. Moore, M. Bouxsein, M. Jimenez, W. S. Chiu, V. Glatt, B. E. Kream, D. J. Handelsman, H. A. Morris, J. D. Zajac, and R. A. Davey. 2007. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J. Bone Miner. Res. 22:347-356.
39. Orimo, H., and T. Shimada. 2005. Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-trans-retinoic acid in SaOS-2 osteosarcoma cell line. Bone 36:866-876.
40. Ornitz, D. M., and P. J. Marie. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16:1446-1465.
41. Parfitt, A. M., M. K. Drezner, F. H. Glorieux, J. A. Kanis, H. Malluche, P. J. Meunier, S. M. Ott, R. R. Recker, et al. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. J. Bone Miner. Res. 2:595-610.
42. Pederson, L., M. Kremer, J. Judd, D. Pascoe, T. C. Spelsberg, B. L. Riggs, and M. J. Oursler. 1999. Androgens regulate bone resorption activity of isolated osteoclasts in vitro. Proc. Natl. Acad. Sci. USA 96:505-510.
43. Rao, L. G., J. N. Wylie, M. S. Kung Sutherland, and T. M. Murray. 1996. 17β-Oestradiol enhances the stimulatory effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity in human osteosarcoma SaOS-2 cells in a differentiation-dependent manner. J. Endocrinol. 148:181-187.
44. Reifenstein, E. C., and F. Albright. 1947. The metabolic effects of steroid hormones in osteoporosis. J. Clin. Investig. 26:24-56.
45. Rochira, V., A. Balestrieri, B. Madeo, L. Zirilli, A. R. Granata, and C. Carani. 2006. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. Eur. J. Endocrinol. 154:175-185.
46. Sato, T., H. Kawano, and S. Kato. 2002. Study of androgen action in bone by analysis of androgen-receptor deficient mice. J. Bone Miner. Metab. 20:326-330.
47. Soule, S. G., G. Conway, G. M. Prelevic, M. Prentice, J. Ginsburg, and H. S. Jacobs. 1995. Osteopenia as a feature of the androgen insensitivity syndrome. Clin. Endocrinol. 43:671-675.
48. Takeuchi, M., H. Kakushi, and M. Tohkin. 1994. Androgens directly stimulate mineralization and increase androgen receptors in human osteoblastlike osteosarcoma cells. Biochem. Biophys. Res. Commun. 204:905-911.
49. Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289:1504-1508.
50. Traianedes, K., M. R. Dallas, I. R. Garrett, G. R. Mundy, and L. F. Bonewald. 1998. 5-Lipoxygenase metabolites inhibit bone formation in vitro. Endocrinology 139:3178-3184.
51. Vandenput, L., J. V. Swinnen, S. Boonen, E. Van Herck, R. G. Erben, R. Bouillon, and D. Vanderschueren. 2004. Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model. J. Bone Miner. Res. 19:1462-1470.
52. Vanderschueren, D., L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson. 2004. Androgens and bone. Endocrinol. Rev. 25:389-425.
53. Venken, K., K. De Gendt, S. Boonen, J. Ophoff, R. Bouillon, J. V. Swinnen, G. Verhoeven, and D. Vanderschueren. 2006. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J. Bone Miner. Res. 21:576-585.
54. Waymire, K. G., J. D. Mahuren, J. M. Jaje, T. R. Guilarte, S. P. Coburn, and G. R. MacGregor. 1995. Mice lacking tissue nonspecific alkaline phosphatase die from seizures due to defective metabolism of vitamin B6. Nat. Genet. 11:45-51.
55. Whyte, M. P. 1994. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocrinol. Rev. 15:439-461.
56. Wilson, M. J., L. Liaw, and P. Koopman. 2005. Osteopontin and related SIBLING glycoprotein genes are expressed by Sertoli cells during mouse testis development. Dev. Dyn. 233:1488-1495.
57. Wiren, K., E. Keenan, X. Zhang, B. Ramsey, and E. Orwoll. 1999. Homologous androgen receptor up-regulation in osteoblastic cells may be associated with enhanced functional androgen responsiveness. Endocrinology 140: 3114-3124.
58. Wiren, K. M., X. Zhang, C. Chang, E. Keenan, and E. S. Orwoll. 1997. Transcriptional up-regulation of the human androgen receptor by androgen in bone cells. Endocrinology 138:2291-2300.
59. Wiren, K. M., X. W. Zhang, A. R. Toombs, V. Kasparcova, M. A. Gentile, S. Harada, and K. J. Jepsen. 2004. Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals. Endocrinology 145:3507-3522.
60. Yeh, S., M. Y. Tsai, Q. Xu, X. M. Mu, H. Lardy, K. E. Huang, H. Lin, S. D. Yeh, S. Altuwaijri, X. Zhou, L. Xing, B. F. Boyce, M. C. Hung, S. Zhang, L. Gan, and C. Chang. 2002. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc. Natl. Acad. Sci. USA 99:13498- 13503.